pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 57 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    BW-20805
    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN… Shanghai Argo Pharmaceutical Co Ltd1 cat
  • Phase 2
    siplizumab
    Vicalex (siplizumab)
    Transplant Rejection ITB-Med AB1 cat
  • Phase 2
    tulisokibart
    tulisokibart
    Systemic Sclerosis (Scleroderma)$MRK Merck & Co., Inc.1 cat
  • Phase 2
← prev
page 1 of 2
next →
131
Pain89
Neurology1
(cilnidipine + tadalafil)
(cilnidipine [INN] + tadalafil)
Systemic Sclerosis (Scleroderma)
AISA Pharma Inc
  • Phase 2
    ACE-1831
    Immunoglobulin G4-Related Disease (IgG4-RD) Acepodia Inc
  • Phase 2
    AZD-0120
    Refractory Multiple Myeloma Gracell Biotechnologies Inc
  • Phase 2
    Autologous Adipose-derived Stem Cells
    Osteoarthritis CellTex Therapeutics Corp
  • Phase 2
    CA-002
    Peanut Allergy Cambridge Allergy Ltd
  • Phase 2
    CNP-106
    Myasthenia Gravis Cour Pharmaceuticals Development Co Inc
  • Phase 2
    CTO-1681
    Cytokine Release Syndrome (Cytokine Storm) CytoAgents Inc
  • Phase 2
    CYP-001
    Graft Versus Host Disease (GVHD) Cynata Therapeutics Ltd
  • Phase 2
    DBV-135
    Milk Allergy DBV Technologies SA
  • Phase 2
    DS-7011
    Cutaneous Lupus Erythematosus Daiichi Sankyo Co Ltd
  • Phase 2
    DSG3-CAART
    Pemphigus Vulgaris$CABA Cabaletta Bio, Inc.
  • Phase 2
    EG-501
    Cognitive Impairment Shenzhen Evergreen Therapeutics Co Ltd
  • Phase 2
    F-652
    Alcoholic Hepatitis Evive Biotech
  • Phase 2
    GCC-4001
    Idiopathic Inflammatory Myopathy (IIM)$ARTV Artiva Biotherapeutics, Inc.
  • Phase 2
    Gene Therapy to Activate Artemis for Severe Combined Immune Deficiency
    Severe Combined Immune Deficiency (SCID) University of California San Francisco
  • Phase 2
    Gene Therapy to Activate IL-2 Gamma Receptor for SCID-X1
    X-Linked SCID Boston Children's Hospital
  • Phase 2
    IM-101
    Myasthenia Gravis ImmunAbs Inc
  • Phase 2
    KBLP-001
    Plaque Psoriasis (Psoriasis Vulgaris) KoBioLabs Inc
  • Phase 2
    LIS-1
    Kidney Transplant Rejection Xenothera SAS
  • Phase 2
    MaaT-013
    Graft Versus Host Disease (GVHD) MaaT Pharma SA
  • Phase 2
    NS-229
    Eosinophilic Granulomatosis with Polyangiitis (Churg-Stra… Nippon Shinyaku Co Ltd
  • Phase 2
    OATD-01
    Pulmonary Sarcoidosis Molecure SA
  • Phase 2
    ORKA-001
    Plaque Psoriasis (Psoriasis Vulgaris)$ORKA Oruka Therapeutics, Inc.
  • Phase 2
    PH-10
    Xantryl
    Atopic Dermatitis (Atopic Eczema)$PVCT PROVECTUS BIOPHARMACEUTICALS, INC.
  • Phase 2
    PVX-108
    Peanut Allergy Aravax Pty Ltd
  • Phase 2
    Peanut SLIT-tablet
    Peanut Allergy ALK-Abello AS
  • Phase 2
    QT-019B
    Systemic Lupus Erythematosus Hangzhou Qihan Biotechnology Co Ltd